ProPhase Labs, Inc. (PRPH) earnings
PRPH earnings moved a median of -0.55% by the close. Quarterly and annual PRPH reports and results, each read against the price at its own news timestamp. Back to the PRPH overview →
32 measured PRPH earnings events.
Where these PRPH earnings landedvs 32 measured PRPH earnings reactions
| Middle 50% of PRPH earnings reactions | -6.13% to +3.08% |
|---|---|
| Median reaction (to close) | -0.55% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 PRPH earnings events with a measured close landed between -6.13% and +3.08%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ProPhase Labs, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -17.82% | |
| Form NT 10-Q ProPhase Labs, Inc. For: Jun 30 | SEC filing · Form NT | +0.00% | -38.78% | |
| Form 10-Q/A ProPhase Labs, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-Q/A ProPhase Labs, Inc. For: Mar 31 | SEC filing · Form 10-Q | -9.63% | +12.25% | |
| Form 10-Q ProPhase Labs, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.44% | |
| Form 10-K ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form 10-K | +24.25% | +36.43% | |
| Form NT 10-Q ProPhase Labs, Inc. For: Mar 31 | SEC filing · Form NT | +0.00% | +5.67% | |
| Form NT 10-K ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form NT | -9.56% | +1.03% | |
| Form 10-Q ProPhase Labs, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.84% | -18.21% | |
| ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 | Press release | -1.91% | -5.08% | |
| Form NT 10-Q ProPhase Labs, Inc. For: Sep 30 | SEC filing · Form NT | +0.00% | -9.28% | |
| Form 10-Q ProPhase Labs, Inc. For: Jun 30 | SEC filing · Form 10-Q | +3.37% | +5.56% | |
| ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 | Press release | -4.20% | -12.95% | |
| Form 10-Q ProPhase Labs, Inc. For: Mar 31 | SEC filing · Form 10-Q | -11.71% | -14.46% | |
| Form NT 10-Q ProPhase Labs, Inc. For: Mar 31 | SEC filing · Form NT | +0.13% | -17.77% | |
| ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 | Press release | -2.46% | +3.31% | |
| Form 10-K/A ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.78% | |
| Form 10-K ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.56% | +3.01% | |
| Form NT 10-K ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form NT | -0.56% | +3.01% | |
| Form 10-Q ProPhase Labs, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.82% | -1.09% | |
| Form NT 10-Q ProPhase Labs, Inc. For: Sep 30 | SEC filing · Form NT | +3.82% | -1.09% | |
| ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 | Press release | +0.32% | -3.73% | |
| Form 10-Q ProPhase Labs, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.88% | -7.00% | |
| Form NT 10-Q ProPhase Labs, Inc. For: Jun 30 | SEC filing · Form NT | +0.00% | +4.33% | |
| PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14 | Press release | — | -5.84% | |
| Form 10-Q ProPhase Labs, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +4.75% | |
| PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9 | Press release | +0.00% | +1.14% | |
| Form 10-K/A ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.44% | |
| Form 10-K ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.30% | +3.94% | |
| Form NT 10-K ProPhase Labs, Inc. For: Dec 31 | SEC filing · Form NT | +0.58% | +1.16% | |
| Form 10-Q ProPhase Labs, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.22% | -3.76% | |
| ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time | Press release | — | +0.44% |
Keep exploring
More PRPH: analyst actions → · SEC filings → · PRPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Daxor Corporation - Closed End Fund (DXR) | 200 | 0.00% | 50% |
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
| Inogen, Inc (INGN) | 197 | +0.31% | 60% |
| Protalix BioTherapeutics, Inc. (DE) (PLX) | 197 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.